Cost-safety-effectiveness analysis of different methods of rabies vaccination

How to cite this article:
Joob B, Wiwanitkit V. Cost-safety-effectiveness analysis of different methods of rabies vaccination. Ann Trop Med Public Health 2016;9:134-5
How to cite this URL:
Joob B, Wiwanitkit V. Cost-safety-effectiveness analysis of different methods of rabies vaccination. Ann Trop Med Public Health [serial online] 2016 [cited 2016 Aug 29];9:134-5. Available from: https://www.atmph.org/text.asp?2016/9/2/134/177402

Dear Sir,

Rabies is a deadly neurological disease. The best prevention is the postexposure rabies vaccination.­ [1] In the present day, there are several techniques for vaccine administration. Both intradermal (ID) and intramuscular (IM) administration can be used and different numbers of injection site are applicable. There are some reports comparing the effectiveness among different techniques. The recent publication by Warrell et al. compared several techniques and can be useful information for further policymaking.­ [2] Nevertheless, the important concern in decisionmaking is the “cost” and “effectiveness.” In addition, the “safety” has to be considered. Here, the author performed an analysis on cost-safety-effectiveness analysis of different methods of rabies vaccination. Data on cost refers to the standard vaccine cost, in US dollars, from the Thai Red Cross Society, Thailand. The effectiveness and safety refer to the published data by Warrell et al[1] The cost-safety-effectiveness analysis can be defined as cost per safe fraction of vaccine effectiveness which can be calculated by “cost/[(1% of adverse effects) × effectiveness].” The data of analysis is shown in [Table 1]. According to the analysis, in term of cost, effectiveness, and safety, the 2-site ID regimen is the most favorable method with the lowest cost with the highest safe effectiveness.

Table 1: Cost-safety-effectiveness analysis

Click here to view

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.

References
1.
Bader MS, McKinsey DS. Postexposur-e prophylaxis for common infectious diseases. Am Fam Physician 2013;88:25-32.
2.
Warrell MJ, Riddell A, Yu LM, Phipps J, Diggle L, Bourhy H, et al. A simplified 4-site economical intradermal post-exposure rabies vaccine regimen: A randomised controlled comparison with standard methods. PLoS Negl Trop Dis 2008;2:e224.

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/1755-6783.177402

Tables

[Table 1]

Paul Mies has now been involved with test reports and comparing products for a decade. He is a highly sought-after specialist in these areas as well as in general health and nutrition advice. With this expertise and the team behind atmph.org, they test, compare and report on all sought-after products on the Internet around the topics of health, slimming, beauty and more. The results are ultimately summarized and disclosed to readers.

LEAVE A REPLY

Please enter your comment!
Please enter your name here